BioXcel Therapeutics, Inc. (BTAI) › Total LiabilitiesBioXcel Therapeutics, Inc. (BTAI) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $2.34M2018: $4.66M2019: $9.50M2020: $13.24M2021: $17.77M2022: $129.08M2023: $130.21M2024: $131.44M2025: $140.38M$140.38M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$140.38M+6.8%2024$131.44M+0.9%2023$130.21M+0.9%2022$129.08M+626.3%2021$17.77M+34.2%2020$13.24M+39.4%2019$9.50M+103.8%2018$4.66M+99.4%2017$2.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share